A randomized, placebo-controlled, blind anti-AIDS clinical trial: safety and immunogenicity of a specific anti-IFN alpha immunization.
Gringeri A, Santagostino E, Mannucci PM, Tradati F, Cultraro D, Buzzi A, Criscuolo M, David A, Guillemot L, Barré-Sinoussi F. J Acquir Immune Defic Syndr. 1994 Sep; 7(9):978-88.